Nabil Hanna

University of Geneva — Switzerland

Medicine · Health Sciences

40h-index6.0kcitations167works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(28), Immune Cell Function and Interaction(27), Mycobacterium research and diagnosis(16), T-cell and B-cell Immunology(14), Immunotherapy and Immune Responses(13)

Publications166 total

Navigating Experimental Metabolomics Knowledge Graphs for Targeted Isolation of Anti-Infective Natural Products
Phytochemistry Letters·2025
Enhancing prioritization strategies of natural extracts: integrating heterogeneous data from metabolomics datasets and biological screenings into knowledge graphs
Phytochemistry Letters·2025
Dictyosteliumdiscoideum–Mycobacterium marinum infection model: a powerful high-throughput screening platform for anti-infective compounds
Frontiers in Microbiology·2025· 3 citedOpen Access
Phenylalkyl Acetophenones and Anacardic Acids from Knema oblongifolia with Synthetic Analogues as Anti-infectives and Antibacterial Agents
ACS Bio & Med Chem Au·2025Open Access
Author Reply to Peer Reviews of Membrane microdomains are crucial for Mycobacterium marinum EsxA-dependent membrane damage, escape to the cytosol and infection
2025
Author response for "Prioritization of novel anti-infective stilbene derivatives by combining metabolomic data organization and a stringent 3R-infection model in a knowledge graph"
2025
Author response for "Prioritization of novel anti-infective stilbene derivatives by combining metabolomic data organization and a stringent 3R-infection model in a knowledge graph"
2025
Prioritization of novel anti-infective stilbene derivatives by combining metabolomic data organization and a stringent 3R-infection model in a knowledge graph
RSC Advances·2025Open Access
The <i>Dictyostelium discoideum – Mycobacterium marinum</i> infection model, a powerful high throughput screening platform for anti-infective compounds
2024Open Access
Discovery of anti-infective compounds against Mycobacterium marinum after biotransformation of simple natural stilbenes by a fungal secretome
Frontiers in Microbiology·2024· 4 citedOpen Access
Membrane microdomains are crucial for <i>Mycobacterium marinum</i> EsxA-dependent membrane damage, escape to the cytosol and infection
2024· 2 citedOpen Access
Prioritization of Novel Anti-infective Stilbene derivatives by Combining Metabolomic Data Organization and a Stringent 3R-infection Model in a Knowledge Graph
2024· 2 citedOpen Access
Discovery of anti-infective compounds against <i>Mycobacterium marinum</i> after biotransformation of simple natural stilbene scaffolds by a fungal secretome
2024· 3 citedOpen Access
Temporal genome-wide fitness analysis of <i>Mycobacterium marinum</i> during infection reveals the genetic requirement for virulence and survival in amoebae and microglial cells
mSystems·2024· 12 citedOpen Access
Application of the RDF framework to integrate heterogenous experimental data of a large chemo- and biodiverse collection from a research collaborative project
2023Open Access
Short Lecture "Targeted isolation of new anti-infective natural products through multi-informative metabolite networks and HPLC-based bioactivity profiling using a 3R infection model"
Planta Medica·2023
Targeted isolation of natural analogs of anti-mycobacterial hit compounds based on the metabolite profiling of a large collection of plant extracts
Frontiers in Natural Products·2023· 6 citedOpen Access
Data from Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions
2023Open Access
Supplementary Data from Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions
2023Open Access
Supplementary Data from Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Don E. Griswold(8), Michael J. DiMartino(5), Kandasamy Hariharan(4), Isaiah J. Fidler(4), Raymond W. Sweet(4), Alemseged Truneh(4), Mitchell E. Reff(4), Roland Newman(4), D Taylor‐Robinson(4), Manjula Reddy(3), Darrell R. Anderson(3), George Poste(3), Paul Chinn(3), Edward F. Webb(3), Gary R. Braslawsky(3), Stephan Köhler(3), Alessandra Occhialini(3), Leonard M. Hillegass(3), Benjamin Bonavida(2), Karen S. Chambers(2)